HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Eun Kyoung Ryu Selected Research

histidylserine

12/2019Vitamin E-Conjugated Phosphopeptide Inhibitor of the Polo-Box Domain of Polo-Like Kinase 1.
10/2012In vivo tumor imaging using polo-box domain of polo-like kinase 1 targeted peptide.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Eun Kyoung Ryu Research Topics

Disease

14Neoplasms (Cancer)
12/2021 - 03/2004
3Alzheimer Disease (Alzheimer's Disease)
01/2008 - 01/2006
1Neoplasm Metastasis (Metastasis)
05/2020
1Hypersensitivity (Allergy)
10/2019
1Bone Resorption
12/2016
1Colonic Neoplasms (Colon Cancer)
10/2014
1Glioma (Gliomas)
11/2013
1Glioblastoma (Glioblastoma Multiforme)
10/2011
1Prostatic Neoplasms (Prostate Cancer)
03/2008
1Memory Disorders (Memory Loss)
01/2008
1Neurodegenerative Diseases (Neurodegenerative Disease)
01/2008

Drug/Important Bio-Agent (IBA)

5Peptides (Polypeptides)IBA
12/2019 - 03/2008
3PhosphopeptidesIBA
12/2019 - 10/2012
3AcetylcholinesteraseIBA
01/2008 - 01/2006
2Polo-Like Kinase 1IBA
12/2019 - 10/2012
2histidylserineIBA
12/2019 - 10/2012
2prolylleucineIBA
12/2019 - 10/2012
2Pharmaceutical PreparationsIBA
10/2014 - 10/2012
2Oleanolic AcidIBA
10/2014 - 11/2013
2Proteins (Proteins, Gene)FDA Link
11/2013 - 10/2011
1TubulinIBA
12/2021
1RadiopharmaceuticalsIBA
11/2021
1Citraconic AnhydridesIBA
01/2021
1GoldIBA
01/2021
1Anti-Bacterial Agents (Antibiotics)IBA
05/2020
1Biomarkers (Surrogate Marker)IBA
12/2019
1Immunoglobulin E (IgE)IBA
10/2019
1Immunoglobulin G (IgG)IBA
10/2019
1PolymersIBA
10/2019
1ginsenoside ReIBA
12/2016
1Biological ProductsIBA
11/2014
1Radioisotopes (Radionuclides)IBA
10/2014
1TriterpenesIBA
10/2014
11,4,7- triazacyclononane- N,N',N''- triacetic acid (NOTA)IBA
11/2013
1ProdrugsIBA
11/2013
1AcidsIBA
11/2013
1Chelating AgentsIBA
11/2013
1IntegrinsIBA
11/2013
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
01/2013
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2013
1Antimitotic AgentsIBA
10/2012
1KR 31831IBA
08/2012
1BenzopyransIBA
08/2012
1Angiogenesis InhibitorsIBA
08/2012
1Hydroxyl RadicalIBA
08/2012
1Antineoplastic Agents (Antineoplastics)IBA
10/2011
1Arginine (L-Arginine)FDA Link
10/2011
1Aspartic Acid (Aspartate)FDA Link
10/2011
1Glycine (Aminoacetic Acid)FDA LinkGeneric
10/2011
1arginyl-glycyl-aspartic acidIBA
10/2011
1Integrin alphaVbeta3IBA
03/2008
1bombesin (7-14)IBA
03/2008
1cyclic arginine-glycine-aspartic acid peptideIBA
03/2008
1(18)F-FB-BBN-RGDIBA
03/2008
1BombesinIBA
03/2008
1Neurotransmitter Agents (Neurotransmitter)IBA
01/2008
1Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA
01/2008
1Cholinergic Agents (Cholinergics)IBA
01/2006
1phoroneIBA
03/2004
1Sulfhydryl Compounds (Thiols)IBA
03/2004
1methyl methanethiosulfonate (MMTS)IBA
03/2004
1dibenzyl disulfideIBA
03/2004
1diallyl disulfide (diallyl disulphide)IBA
03/2004
1DisulfidesIBA
03/2004

Therapy/Procedure

2Therapeutics
12/2019 - 10/2012